| | Roundtable: Creating Sustainable Change in HCP Engagement Tuesday, December 8 | 11am ET / 8am PT To succeed in today’s environment, biopharmaceutical companies must leverage analytics and adopt innovative approaches to engage HCPs and improve outcomes for their customers and communities. Join us for a roundtable discussion with leading industry innovators to discuss how biopharma manufacturers can successfully increase and improve HCP engagement. Register now. |
Lilly partners with Samsung to boost COVID-19 antibody manufacturing amid supply concerns Provider groups including AHA, AMA call for White House to work with Biden administration Will we still be wearing masks at Thanksgiving 2021? Here's what Fauci says CureVac, armed with COVID-19 vaccine deal, plots 'pandemic-scale' Euro manufacturing expansion HHS calls on FDA to speed up reviews of lab-developed COVID-19 tests after backlog Warren Buffett's Berkshire bets big on AbbVie, Bristol Myers, Merck, Pfizer as COVID drives healthcare investment AHIP: Price gouging gets worse for out-of-network COVID-19 tests Biopharma roundup: Moderna snares 5M-dose U.K. supply deal; BMS' CAR-T hopes dampened by pandemic inspection delays Featured Story | By Eric Sagonowsky A week after Eli Lilly won an FDA emergency authorization for its COVID-19 antibody, concerns over limited supplies are already popping up, and the company is bringing in an experienced manufacturing partner to help with the global scale-up. read more |
| |
|---|
|
Top Stories By Tina Reed Top provider groups are urging the White House to share critical COVID-19 information with the incoming Biden Administration to prevent any potential lapses in care for patients. read more By Tina Reed When the nation's top infectious disease expert Anthony Fauci was asked on Tuesday whether we'd still be wearing masks at Thanksgiving next year, it seemed like a perfect opening for some good news. Unfortunately, his answer was less satisfying than a can of cranberry sauce. read more By Fraiser Kansteiner CureVac, fresh off a large EU supply deal, is looking to build an integrated vaccine manufacturing network across Europe. It plans to enlist a slate of CDMOs and suppliers across the bloc, with the goal to boost capacity for up to 300 million shot doses in 2021 and upward of 600 million doses in 2022. read more By Robert King The Department of Health and Human Services is pushing the Food and Drug Administration to speed up reviews of lab-developed COVID-19 tests, and is asking the National Cancer Institute for help. read more By Angus Liu As the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors have diverted their money to the sector. Warren Buffett is among those who have now doubled down on their commitments to the biopharma industry as his Berkshire Hathaway plowed billions of dollars into AbbVie, Bristol Myers Squibb, Merck and Pfizer. read more By Robert King A new AHIP survey found that costs for out-of-network COVID-19 tests have been going up since a July survey. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner The U.K. snapped up 5 million Moderna doses Monday. The FDA postponed its decision on BMS' liso-cel after pandemic delays kept inspectors from reviewing a Lonza facility in Texas. Infectious disease experts aren't feeling confident about prescribing an approved shot, a recent survey showed. Plus, an Ohio senator will take part in J&J's vaccine trial. read more |
